- Home
- LSF vs VNRX Comparison
LSF vs VNRX Comparison
Compare LSF & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 38.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSF | VNRX |
|---|---|---|
| Price | $2.31 | $0.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $3.17 |
| AVG Volume (30 Days) | 118.3K | ★ 2.6M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,146,862.00 | $1,472,007.00 |
| Revenue This Year | $18.05 | $55.33 |
| Revenue Next Year | $17.53 | $493.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | 14.48 |
| 52 Week Low | $2.18 | $0.27 |
| 52 Week High | $8.99 | $0.94 |
Technical Indicators
Market Signals| Indicator | LSF | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 34.84 |
| Support Level | $2.18 | $0.28 |
| Resistance Level | $2.78 | $0.34 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 27.67 | 27.24 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.